AxoGen Profile

36.00
USD 0.15  0.42%
16%
41%

Exercise or conversion by Shawn McCarrey of 55000 shares of AxoGen subject to Rule 16b-3

AxoGen insider trading alert for exercise of employee stock option (right to purchase) by Shawn McCarrey, SVP Sales, on August 25, 2018. This event was filed by Axogen Inc with SEC on 2018-08-09. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

AxoGen Summary

AxoGen (AXGN) is traded on BATS Exchange in USA. It is located in FLORIDA U.S.A and employs 184 people. AxoGen is listed under Medical Equipment category by Fama And French industry classification.The company currently falls under 'Mid-Cap' category with current market capitalization of 1.38 B. AxoGen conducts business under Healthcare sector and is part of Medical Devices industry. This company has 38.32 M outstanding shares of which 2.64 M shares are presently shorted by private and institutional investors with about 4.5 trading days to cover. AXOGEN INC currently holds about 133.56 M in cash with (13.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.48.
Check AxoGen Probability Of Bankruptcy

Ownership Allocation (%)

AxoGen Target Price Odds Analysis

Odds Below 36.0HorizonTargetOdds Above 36.0
14.51%30 days 36.00 85.40%
Based on normal probability distribution, the odds of AxoGen to move above current price in 30 days from now is about 85.4% (This AxoGen probability density function shows the probability of AxoGen Stock to fall within a particular range of prices over 30 days) .

AxoGen Top Holders

AxoGen Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Essex Woodlands Management IncCommon Shares3.7 M186.5 M
Blackrock IncCommon Shares2.4 M122.5 M
View AxoGen Diagnostics

AxoGen Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

AxoGen Key Fundamentals

AxoGen Against Markets

AxoGen Current Ratings

AxoGen 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
51 
Equity ratings for AxoGen are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
AxoGen, Inc. develops and markets surgical solutions for peripheral nerve injuries. The company provides its products to hospitals, surgery centers, and military hospitals in the United States, Canada, the United Kingdom and other European countries, and internationally. AxoGen operates under Medical Devices classification in USA and traded on BATS Exchange. It employs 184 people. more
Fama & French Medical Equipment
Medical Equipment
Fama & French Classification
AxoGen SEC Filings
AxoGen SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameAxoGen
CEO and President and DirectorKaren ZaderejView All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Specialization
Healthcare, Medical Devices
InstrumentUSA Stock View All
RegionNorth America
LocationFLORIDA U.S.A
Business Address13631 Progress Boulevard
ExchangeBATS Exchange
CIK Number0000805928
CUSIP523251106
SectorHealthcare
IndustryMedical Devices
BenchmarkDOW
Websitewww.axogeninc.com
Phone386 462 6800
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2019
Most Recent QuarterJune 30, 2018
Last Fiscal Year EndDecember 31, 2017
Date Short InterestAugust 31, 2018

AxoGen Directors

AxoGen Corporate Directors

Robert Rudelius Independent Director
Amy Wendell Director
Joseph Mandato Independent Director
Check also Trending Equities. Please also try Price Ceiling Movement module to calculate and plot price ceiling movement for different equity instruments.
Search macroaxis.com